NDE1

protein-coding

nudE neurodevelopment protein 1, the group of MicroRNA protein coding host genes

Gene summary

This gene encodes a member of the nuclear distribution E (NudE) family of proteins. The encoded protein is localized at the centrosome and interacts with other centrosome components as part of a multiprotein complex that regulates dynein function. This protein plays an essential role in microtubule organization, mitosis and neuronal migration. Mutations in this gene cause lissencephaly 4, a disorder characterized by lissencephaly, severe brain atrophy, microcephaly, and severe cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2012]

MANE transcript

NM_017668.3

Inheritance

AR

ClinVar variants

P:14U:117B:56

Top phenotype

Lissencephaly 4 with microcephaly; Microhydranencephaly

gnomAD constraint

pLI —, LoF o/e 0.37

Max pathogenic AF

—

Genomic locus

chr16:15,643,267-15,734,691

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~91.4 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

lissencephaly 4DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0013527

Submitter: G2P

lissencephaly 4MODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0013527

Submitter: Ambry Genetics

microcephaly with lissencephaly and/or hydranencephalyDEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0700116

Submitter: ClinGen

The relationship between *NDE1* and microcephaly with lissencephaly and/or hydranencephaly was first reported in 2011 (PMID: 21529752, PMID: 21529751). Microcephaly with lissencephaly and/or hydranencephaly is a brain disorder that is characterized by extreme microcephaly (typically head circumference of less than 10 standard deviations (SD) below the mean), profound motor and intellectual disability, spasticity, and incomplete cerebral formation. Patients demonstrate cortical dysgenesis ranging from simplification to pachygyria/lissencephaly to hydranencephaly. Agenesis of the corpus callosum as well as hypoplasia of the brainstem and cerebellum are typically present. These presentations were lumped into a single disease curation, consistent with shared molecular mechanism and mode of inheritance (Autosomal Recessive, AR). At least 8 variants in *NDE1* have been identified in individuals with microcephaly with lissencephaly and/or hydranencephaly over 14 years (PMID: 21529751, 34562061,21529752, 22526350, 30637988, 29191162, 23704059). These variants include loss of function and missense variants in highly conserved residues. In the literature, patients with severe microcephaly have been identified with deletions of 16p13.11 (including *NDE1*) and an additional *NDE1* variant on the second allele (PMID: 23704059, PMID: 29191162). Due to the prominent phenotype, these cases have been scored. More evidence is available in the literature, but the maximum genetic evidence (12 pts) was reached. This gene-disease relationship is also supported by animal models and in vitro data. *NDE1* was first associated with cerebral cortical size in 2004 (PMID: 15473967). Initially, *NDE1* was identified as a *LIS1* interacting protein (PMID: 11163258). *NDE1* is part of a multiprotein complex that regulates dynein function, playing an essential role in microtubule organization, mitosis and neuronal migration. Experimental data from mouse and yeast studies supports the role of *NDE1* in brain malformation. *NDE1* is strongly expressed in the developing mouse cerebral cortex (PMID: 11163258). Null mouse models of *NDE1* demonstrate neuronal migration defects, resulting in microcephaly, including fewer neurons and a thin superficial cortical layer (PMID: 15473967). In summary, there is definitive evidence supporting the relationship between *NDE1* and microcephaly with lissencephaly and/or hydranencephaly. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.This classification was approved by the ClinGen Brain Malformation GCEP on December 10, 2024 (SOP 11).

hydranencephalySUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0016344

Submitter: Orphanet

microlissencephalySUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0015204

Submitter: Orphanet

NDE1-related microhydranencephalySUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0011504

Submitter: Orphanet

microcephaly with lissencephaly and/or hydranencephalySTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0700116

Submitter: PanelApp Australia

lissencephaly 4STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0013527

Submitter: Labcorp Genetics (formerly Invitae)

lissencephaly 4STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0013527

Submitter: Laboratory for Molecular Medicine

This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.

NDE1-related microhydranencephalyLIMITED

Inheritance Pattern: Unknown

Disease ID:MONDO:0011504

Submitter: Labcorp Genetics (formerly Invitae)

Clinical Genomic Database (CGD)

Lissencephaly 4 with microcephaly; MicrohydranencephalyAR

Manifestation: Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 10762554; 21529751; 21529752; 22526350Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to NDE1 variants in ClinVar

29 Conditions Cataloged
Familial thoracic aortic aneurysm and aortic dissectionTotal: 909
Aortic aneurysm, familial thoracic 4Total: 812
not providedTotal: 447
not specifiedTotal: 163
Inborn genetic diseasesTotal: 57
Megacystis-microcolon-intestinal hypoperistalsis syndrome 2Total: 56
Visceral myopathy 2Total: 54
Lissencephaly 4Total: 49

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_017668.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
7
clinvar
49
clinvar
1
clinvar
57
missense
1
clinvar
104
clinvar
6
clinvar
111
nonsense
3
clinvar
2
clinvar
3
clinvar
8
start loss
1
clinvar
1
frameshift
3
clinvar
1
clinvar
1
clinvar
5
splice donor/acceptor (+/-2bp)
2
clinvar
1
clinvar
2
clinvar
5
Total86117551187

Highest pathogenic variant AF is 0.000058242127

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 86 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_017668.3RefSeqNP_060138.18MANE Select
ENST00000396354.6EnsemblENSP00000379642.18MANE Select
NM_001143979.2RefSeqNP_001137451.18Standard
ENST00000396355.5EnsemblENSP00000379643.18Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
nde1Danio rerio

Structure: head

Quality: decreased size

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Signal Transduction
  • Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal
  • Amplification of signal from the kinetochores
  • Mitotic Spindle Checkpoint
  • Cell Cycle Checkpoints

Biological Process

  • G2/M transition of mitotic cell cycle
  • establishment of mitotic spindle orientation
  • neuron migration
  • microtubule nucleation
  • chromosome segregation

Molecular Function

  • protein binding
  • microtubule binding
  • protein domain specific binding
  • identical protein binding

Cellular Component

  • kinetochore
  • condensed chromosome kinetochore
  • centrosome
  • cytosol
  • kinesin complex

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000396355
Coding exons
8
Length
83087
Individuals with no LoFs
125713
Homozygous LoFs
0
Heterozygous LoFs
34
Defined
125747
p
0.000135
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense-1.132462011.220.00001402175
Missense (PolyPhen)4548.2190.93324591
Synonymous-1.359983.31.190.00000603652
Loss of Function2.56719.10.3670.00000120210

Population LoF Frequency

PopulationCAFp-valueStatus
African0.0000620.000062rare
Latino/Admixed American0.000120.00012rare
Ashkenazi Jewish0.0000990.000099rare
East Asian0.000110.00011rare
Finnish0.0000460.000046rare
European (Non-Finnish)0.000150.00015rare
South Asian0.000200.00020rare
Other0.000330.00033rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Required for centrosome duplication and formation and function of the mitotic spindle. Essential for the development of the cerebral cortex. May regulate the production of neurons by controlling the orientation of the mitotic spindle during division of cortical neuronal progenitors of the proliferative ventricular zone of the brain. Orientation of the division plane perpendicular to the layers of the cortex gives rise to two proliferative neuronal progenitors whereas parallel orientation of the division plane yields one proliferative neuronal progenitor and a post- mitotic neuron. A premature shift towards a neuronal fate within the progenitor population may result in an overall reduction in the final number of neurons and an increase in the number of neurons in the deeper layers of the cortex. {ECO:0000269|PubMed:17600710, ECO:0000269|PubMed:21529752}.;
Disease
DISEASE: Lissencephaly 4 (LIS4) [MIM:614019]: A neurodevelopmental disorder characterized by lissencephaly, severe brain atrophy, extreme microcephaly, and profound mental retardation. {ECO:0000269|PubMed:21529751, ECO:0000269|PubMed:21529752}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Microhydranencephaly (MHAC) [MIM:605013]: A severe neurodevelopmental disorder characterized by microcephaly, severe motor and mental retardation, spasticity, and brain malformations that include gross dilation of the ventricles with complete absence of the cerebral hemispheres or severe delay in their development. {ECO:0000269|PubMed:22526350}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.169

Intolerance Scores

LoFtool
0.135
RVIS EVS
-0.82
RVIS percentile EVS
11.77

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
S
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.824

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.